Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Trovagene Inc (NASDAQ:TROV)

5.31
Delayed Data
As of May 27
 -0.04 / -0.75%
Today’s Change
2.85
Today|||52-Week Range
13.58
-1.67%
Year-to-Date
No recent news for Trovagene Inc.

Today’s Trading

Previous close5.35
Today’s open5.34
Day’s range5.10 - 5.37
Volume281,454
Average volume (3 months)708,428
Market cap$153.8M
Dividend yield--
Data as of 4:00pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)-37.50%
Earnings growth (this year)-21.33%
Earnings growth (next 5 years)--
Revenue growth (last year)+11.65%
P/E ratioNM
Price/Sales456.64
Price/Book3.14

Competitors

 Today’s
change
Today’s
% change
VCYTVeracyte Inc-0.08-1.47%
OXFDOxford Immunotec Glo...-0.20-2.18%
CALACalithera Bioscience...0.000.00%
TRILTrillium Therapeutic...-0.04-0.38%
Data as of 4:00pm ET, 05/27/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)-$0.33
Annual revenue (last year)$312.8K
Annual profit (last year)-$27.5M
Net profit margin-8,781.98%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
William J. Welch
Chief Scientific Officer
Mark Erlander
Corporate headquarters
San Diego, California

Forecasts

Partner Offers

Search for Jobs